SurModics (SRDX) Tops Q2 EPS by 13c
Tweet
Share
E-mailGet Alerts SRDX Hot Sheet
Price: $42.98 --0%
Financial Fact:
Total operating costs and expenses: 14.07M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Financial Fact:
Total operating costs and expenses: 14.07M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Join SI Premium – FREE
SurModics (NASDAQ: SRDX) reported Q2 EPS of ($0.40), $0.13 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $27.2 million versus the consensus estimate of $25.86 million.
For earnings history and earnings-related data on SurModics (SRDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- YETI Holdings, Inc. (YETI) Tops Q2 EPS by 12c
- Park Dental Partners, Inc. (PARK) Tops Q2 EPS by 28c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
